KORU MEDICAL SYSTEMS, INC. Financials KORU Medical Systems, Inc.
Equities
KRMD
US7599101026
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.31 USD | -0.43% |
|
+3.59% | -5.91% |
| 05-01 | Earnings Flash (KRMD) KORU MEDICAL SYSTEMS Posts Q1 Revenue $8.2M, vs. Street Est of $7.5M | MT |
| 05-01 | Transcript : KORU Medical Systems, Inc., Q1 2024 Earnings Call, May 01, 2024 |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 257.9 | 264.5 | 133.7 | 161.6 | 112.1 | 105.7 | - | - |
| Enterprise Value (EV) 1 | 257.9 | 264.5 | 133.7 | 161.6 | 112.1 | 105.7 | 105.7 | 105.7 |
| P/E ratio | 653 x | -201 x | -30 x | -18.8 x | -8.18 x | -14.6 x | -27.5 x | -69.3 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 11.1 x | 10.9 x | 5.69 x | 5.79 x | 3.93 x | 3.33 x | 2.81 x | 2.36 x |
| EV / Revenue | 11.1 x | 10.9 x | 5.69 x | 5.79 x | 3.93 x | 3.33 x | 2.81 x | 2.36 x |
| EV / EBITDA | 45.9 x | 72.3 x | -75.3 x | -26.5 x | -18.6 x | -28.9 x | 264 x | 25.8 x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Price to Book | - | - | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | 39,502 | 43,943 | 44,561 | 45,280 | 45,669 | 45,764 | - | - |
| Reference price 2 | 6.530 | 6.020 | 3.000 | 3.570 | 2.455 | 2.310 | 2.310 | 2.310 |
| Announcement Date | 20-02-25 | 21-03-23 | 22-03-02 | 23-03-08 | 24-03-13 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 23.16 | 24.18 | 23.49 | 27.9 | 28.52 | 31.75 | 37.64 | 44.83 |
| EBITDA 1 | 5.615 | 3.661 | -1.775 | -6.096 | -6.03 | -3.66 | 0.4 | 4.101 |
| EBIT 1 | 0.5857 | 1.606 | -5.598 | -10.78 | -10.27 | -7.949 | -4.627 | -1.902 |
| Operating Margin | 2.53% | 6.64% | -23.83% | -38.65% | -36.01% | -25.04% | -12.29% | -4.24% |
| Earnings before Tax (EBT) 1 | 0.6964 | -1.194 | -6.364 | -10.68 | -9.774 | -7.829 | -4.491 | -1.729 |
| Net income 1 | 0.5644 | -1.212 | -4.563 | -8.661 | -13.74 | -7.317 | -4.023 | -1.546 |
| Net margin | 2.44% | -5.01% | -19.42% | -31.05% | -48.18% | -23.05% | -10.69% | -3.45% |
| EPS 2 | 0.0100 | -0.0300 | -0.1000 | -0.1900 | -0.3000 | -0.1580 | -0.0840 | -0.0333 |
| Free Cash Flow | - | - | - | - | - | - | - | - |
| FCF margin | - | - | - | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 20-02-25 | 21-03-23 | 22-03-02 | 23-03-08 | 24-03-13 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 6.491 | 6.244 | 6.547 | 7.76 | 7.345 | 7.393 | 6.936 | 7.003 | 7.186 | 8.198 | 7.577 | 7.845 | 8.088 | 9.111 | 9.097 |
| EBITDA 1 | -0.5853 | -1.854 | -2.367 | -0.3751 | -1.552 | -1.97 | -2.207 | -0.8903 | -0.9627 | -0.9427 | -1.153 | -0.7993 | -0.6457 | 0.037 | -0.113 |
| EBIT 1 | -2.111 | -2.794 | -3.293 | -1.529 | -2.511 | -3.008 | -3.218 | -1.791 | -2.198 | -1.961 | -2.25 | -1.964 | -1.77 | -1.237 | -1.37 |
| Operating Margin | -32.53% | -44.74% | -50.3% | -19.71% | -34.19% | -40.69% | -46.4% | -25.57% | -30.58% | -23.93% | -29.7% | -25.03% | -21.89% | -13.58% | -15.06% |
| Earnings before Tax (EBT) 1 | -1.444 | -3.135 | -3.632 | -1.497 | -2.411 | -2.988 | -3.096 | -1.669 | -2.021 | -1.936 | -2.21 | -1.944 | -1.73 | -1.197 | -1.33 |
| Net income 1 | -1.068 | -2.538 | -2.921 | -1.226 | -1.977 | -2.411 | -2.496 | -1.368 | -7.466 | -1.936 | -2.018 | -1.789 | -1.566 | -1.107 | -1.211 |
| Net margin | -16.46% | -40.64% | -44.62% | -15.79% | -26.91% | -32.61% | -35.98% | -19.54% | -103.9% | -23.62% | -26.63% | -22.8% | -19.36% | -12.15% | -13.31% |
| EPS 2 | -0.0200 | -0.0600 | -0.0700 | -0.0300 | -0.0400 | -0.0500 | -0.0500 | -0.0300 | -0.1600 | -0.0400 | -0.0420 | -0.0400 | -0.0360 | -0.0233 | -0.0267 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 22-03-02 | 22-05-04 | 22-08-03 | 22-11-09 | 23-03-08 | 23-05-04 | 23-08-09 | 23-11-08 | 24-03-13 | 24-05-01 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - |
| ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - | - | - | - |
| Capex 1 | - | - | - | - | 0.78 | 0.5 | 0.6 | - |
| Capex / Sales | - | - | - | - | 2.75% | 1.57% | 1.59% | - |
| Announcement Date | 20-02-25 | 21-03-23 | 22-03-02 | 23-03-08 | 24-03-13 | - | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
2.31
USD
Average target price
3.5
USD
Spread / Average Target
+51.52%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -5.91% | 106M | |
| -4.02% | 184B | |
| -0.75% | 109B | |
| -2.97% | 68.37B | |
| +4.48% | 51.56B | |
| +9.09% | 44.69B | |
| +4.37% | 41.49B | |
| +3.12% | 26.75B | |
| +4.10% | 26.7B | |
| +15.38% | 25.68B |
- Stock Market
- Equities
- KRMD Stock
- Financials KORU Medical Systems, Inc.